Consultez les derniers articles autour de la maladie de Willebrand.

Dernière mise à jour : Lundi 20 juin 2022

Determining the incidence of postpartum haemorrhage among Ontario women with and without inherited bleeding disorders: A population‐based cohort study

Postpartum haemorrhage (PPH) is an adverse obstetrical outcome and a leading cause of global maternal morbidity and mortality. PPH is associated with repeat hospital admissions, ischemic organ injury and...
Lire la suite

Haemophilia 2022; AOP: 10.1111/hae.14594
Julia C. Hews‐Girard et al.

Anesthetic Management of von Willebrand Disease in Pregnancy: A Retrospective Analysis of a Large Case Series

The institution's Research Patient Data Registry was searched for patients with vWD hospitalized for delivery between January 1, 2000 and January 2, 2019. Data extracted from patient records included:...
Lire la suite

Obstetric Anesthesia Digest 2022; 42(2): 91
Reale, S.C. et al.

Bone health in haemophilia carriers and persons with von Willebrand disease: A large database analysis

Bone health is crucial for the health and well‐being of every individual. About 1.5 million individuals in the United States suffer from osteoporosis‐related fractures every year and it has...
Lire la suite

Haemophilia 2022; AOP: 10.1111/hae.14565
Divyaswathi Citla‐Sridhar et al.

Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long‐term prophylaxis: An expert opinion paper from an Italian panel

Von Willebrand factor (VWF) is a large multimeric plasma glycoprotein involved in primary hemostasis (adhesion of platelets to subendothelium after vascular injury and platelet aggregation) which acts as the carrier of coagulation factor VIII, which is necessary for the clotting cascade, thus preventing its degradation. The quantitative or qualitative defect of VWF causes von Willebrand disease (VWD), which is the most common inherited bleeding disorder...
Lire la suite

European Journal Of Haematology 2022; AOP: 10.1111/ejh.13785
Giancarlo Castaman et al.

Découvrez WillebrandXPERTet ses fonctionnalités en quelques instants